Segal Trials Participation in Study Shows Positive Results From Phase 3 EMERGENT-2 KarXT in Schizophrenia

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Source:
    Business Wire (English), 08/23/2022